Shanghai Henlius Biotech Inc. (HKG: 2696) has announced a strategic partnership with China Resource Medicine Commercial Holdings Ltd. aimed at enhancing product accessibility across the market. Under the terms of the agreement, the two companies will collaborate on product marketing promotion, channel expansion, and supply chain management, although financial details of the deal remain undisclosed.
In addition to these initiatives, the partnership will explore innovative “healthcare + Internet” business models, seeking to merge traditional pharmaceutical manufacturing and supply chain services with cutting-edge internet healthcare technologies. The collaboration aims to facilitate the expansion of high-quality medical resources, promote a balanced regional distribution, and develop a more efficient medical service system tailored to patient needs.- Flcube.com
